Value Bridge — BROADLAWNS MEDICAL CENTER
Current $-8M → Target $-5M (+$3.7M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-8.5M
Current EBITDA
$-4.7M
Target EBITDA
+$3.7M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$0.8M
Payer Mix Optimization
$2.0M
Cost to Collect Reduction
$0.7M
Clean Claim Improvement
$0.5M
Volume & Rate Growth
$3.4M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-8M to $-5M. The highest-impact lever is Volume & Rate Growth at $1.4M probability-weighted.
IC talking point: "We see $4M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $41M in equity value creation."